Free Trial

Kinaxis (TSE:KXS) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Kinaxis logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Royal Bank of Canada raised its price target on Kinaxis from C$200 to C$210 and kept an outperform rating, implying about 32.6% upside from the previous close.
  • Analyst sentiment is broadly positive, with six Buy ratings and one Hold rating; the consensus price target stands at C$201.78 despite several firms trimming their targets recently.
  • Kinaxis shares rose to C$158.40 on Friday after reporting quarterly EPS of C$1.45 and revenue of C$230.19 million, while the company continues to post solid profitability and strong liquidity metrics.
  • Five stocks we like better than Kinaxis.

Kinaxis (TSE:KXS - Get Free Report) had its price target upped by investment analysts at Royal Bank Of Canada from C$200.00 to C$210.00 in a research report issued to clients and investors on Friday,BayStreet.CA reports. The firm currently has an "outperform" rating on the stock. Royal Bank Of Canada's price target would suggest a potential upside of 32.58% from the stock's previous close.

Other research analysts also recently issued research reports about the company. TD Securities reduced their price objective on Kinaxis from C$229.00 to C$200.00 and set a "buy" rating on the stock in a report on Friday, March 6th. Canadian Imperial Bank of Commerce lowered their target price on Kinaxis from C$203.00 to C$171.00 in a research note on Friday, April 17th. Scotiabank cut their price target on Kinaxis from C$240.00 to C$200.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 4th. Canaccord Genuity Group decreased their price target on Kinaxis from C$225.00 to C$200.00 in a report on Friday, March 6th. Finally, BMO Capital Markets upped their target price on shares of Kinaxis from C$180.00 to C$185.00 in a research report on Friday. Six investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Kinaxis currently has an average rating of "Moderate Buy" and a consensus price target of C$201.78.

Read Our Latest Stock Report on Kinaxis

Kinaxis Price Performance

KXS traded up C$5.44 during midday trading on Friday, hitting C$158.40. The company had a trading volume of 92,942 shares, compared to its average volume of 138,576. Kinaxis has a twelve month low of C$117.22 and a twelve month high of C$212.45. The company has a market capitalization of C$4.38 billion, a PE ratio of 64.65, a P/E/G ratio of 3.60 and a beta of 0.68. The company has a debt-to-equity ratio of 11.39, a quick ratio of 2.29 and a current ratio of 1.97. The firm's 50-day simple moving average is C$138.87 and its 200-day simple moving average is C$153.99.

Kinaxis (TSE:KXS - Get Free Report) last announced its earnings results on Wednesday, May 6th. The company reported C$1.45 earnings per share (EPS) for the quarter. Kinaxis had a net margin of 12.90% and a return on equity of 16.46%. The company had revenue of C$230.19 million for the quarter. Equities research analysts predict that Kinaxis will post 4.2526231 EPS for the current fiscal year.

About Kinaxis

(Get Free Report)

Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm's flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation. Kinaxis's S&OP solution capabilities include supply and demand planning, capacity and inventory planning, and inventory management. The firm has operations in North America, Europe, and Asia-Pacific regions.

See Also

Analyst Recommendations for Kinaxis (TSE:KXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kinaxis Right Now?

Before you consider Kinaxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.

While Kinaxis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines